Ivermectin mass drug administration for onchocerciasis elimination: can it reduce the prevalence of scabies in Ethiopia? | Zendy

Tsigereda Amsalu | Zendy; Wendemagegn Enbiale | Zendy; Neguse Manaye | Zendy; Ashenafi Ayalew | Zendy; Addisu Workineh | Zendy; Henry J.C. de Vries | Zendy; Johan van Griensven | Zendy

Open Access

Ivermectin mass drug administration for onchocerciasis elimination: can it reduce the prevalence of scabies in Ethiopia?

Author(s) -

Tsigereda Amsalu,

Wendemagegn Enbiale,

Neguse Manaye,

Ashenafi Ayalew,

Addisu Workineh,

Henry J.C. de Vries,

Johan van Griensven

Publication year - 2022

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.15975

Subject(s) - ivermectin , onchocerciasis , scabies , mass drug administration , onchocerca volvulus , medicine , filariasis , drug , antiparasitic agent , administration (probate law) , drug administration , dermatology , veterinary medicine , environmental health , immunology , pharmacology , helminths , population , political science , law

While ivermectin mass drug administration (MDA) has been implemented since long for onchocerciasis elimination, there is doubt whether this would also be effective for scabies control. If effective, this would allow integration of both programs. We compared scabies prevalence in districts implementing ivermectin MDA for the onchocerciasis elimination program and those not implementing the intervention in Amhara region, Ethiopia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research